Crackdown on Deceptive Claims: FSSAI Bans Popular Health Supplements FOLINEURO Syrup and Neuherbs TRUE VITAMIN

NEW DELHI — In a major regulatory enforcement action aimed at safeguarding public health, India’s top food safety regulator has prohibited the sale and distribution of two widely marketed health supplements over non-compliant labeling and deceptive branding.

The Food Safety and Standards Authority of India (FSSAI) issued immediate prohibition orders against Vatave Health Care’s “FOLINEURO Syrup” and Global Healthfit Retail’s “Neuherbs TRUE VITAMIN.” The enforcement orders, announced officially via social media, highlight severe breaches of national labeling regulations, including misleading trade names, unauthorized packaging imagery, and unapproved product classification categories intended to sway consumer choice.

Anatomy of the Violations: Brain Claims and Unrecognized Trade Names

The regulatory body’s investigation revealed distinct statutory failures for both products:

1. FOLINEURO Syrup (Vatave Health Care)

FSSAI instituted a total ban covering the manufacture, processing, storage, marketing, and distribution of “FOLINEURO Syrup – Folinic Acid Syrup.”

• Misleading Visuals & Names: The combination of the trade name “FOLINEURO” with a prominent illustration of a human brain on the front packaging created a false impression that the product possessed targeted therapeutic benefits for neurological function.

• Regulatory Misclassification: The manufacturer labeled the product as a “Nutritional Food Supplement”—a designation that does not legally exist under the Food Safety and Standards (Health Supplements and Nutraceuticals) Regulations, 2016.

2. Neuherbs TRUE VITAMIN (Global Healthfit Retail India)

In a parallel directive, the regulator halted sales of “Neuherbs TRUE VITAMIN,” targeting the product’s core branding.

• Unapproved Nomenclature: The term “TRUE VITAMIN” is neither defined nor recognized under current Indian food laws.

• Consumer Deception: The regulator cited breaches under the Advertising and Claims Regulations (2018) and Labelling and Display Regulations (2020), noting that prefixing or suffixing terms like “True” implies absolute efficacy or superior authenticity that lacks scientific and legal backing.

Global Healthfit Retail has been directed to immediately stop sales, remove all misleading labels and advertisements, and submit an Action Taken Report (ATR) within 30 days.

Part of a Broader Regulatory Crackdown

This double-ban is not an isolated event but the latest move in FSSAI’s intensified nationwide campaign to police the rapidly expanding wellness sector.

                                 FSSAI COMPLIANCE CHECKLIST FOR SUPPLEMENTS
                                 
   [✓] Standardized Category          Must be explicitly labeled "HEALTH SUPPLEMENT" or "NUTRACEUTICAL"
   [✓] Statutory Warning             Must prominently display "NOT FOR MEDICINAL USE"
   [✓] No Disease Claims              Cannot claim to treat, cure, or prevent human diseases
   [✓] Scientific Backing            All health claims require prior regulatory approval & proof
   [✓] Clear FSSAI Identity          Must feature a valid 14-digit FSSAI license number on label

In June 2026 alone, FSSAI issued formal notices to 15 major consumer food brands—including industry giants like Nestlé, KFC, and Open Secret—for utilizing ambiguous or unverified marketing phrases like “healthy,” “zero maida,” and “organic.” FSSAI’s stance remains firm: product naming and visuals cannot bypass statutory health standards to influence consumer choice without clinical validation.

What the Law Mandates

Under the Food Safety and Standards Act, 2006 and its subsequent amendments, dietary supplements operate under clear statutory boundaries:

• Disease Prevention Prohibited: Supplements cannot state or imply that they prevent, treat, or cure medical conditions.

• Mandatory Disclaimers: Labels must clearly display the statement “NOT FOR MEDICINAL USE” alongside a clear target audience and purpose.

• Scientific Proof: Any functional health claim must be backed by peer-reviewed evidence and pre-approved by FSSAI.

Expert Commentary: The Medical and Public Health Perspective

Health experts have welcomed FSSAI’s assertive enforcement while highlighting the broader public health issues surrounding over-the-counter supplements.

“The Indian nutraceutical market has expanded significantly, with consumers increasingly seeking products for brain health, immunity, and general wellness. However, many products make claims that go beyond what’s scientifically established or legally permitted. Consumers often assume that products available in the market have been thoroughly vetted for their health claims. FSSAI’s actions serve as an important reminder that brand names and packaging imagery can create impressions that aren’t backed by evidence.”

— Dr. Anjali Sharma, Public Health Nutritionist and former advisor to India’s Ministry of Health and Family Welfare

Medical professionals emphasize that while folinic acid (a form of folate) plays a legitimate role in cellular function and hematology, presenting it in an over-the-counter syrup with brain graphics can lead patients to self-medicate for complex neurological disorders rather than seeking professional medical care.

Practical Guidance for Consumers

To navigate the crowded health supplement market safely, health-conscious consumers should adopt these practical steps:

1. Ignore Front-of-Pack Marketing: Highlighting terms like “Brain Booster,” “True,” or “Pure” on the front display does not equal proven medical benefit. Look directly at the back panel.

2. Verify the FSSAI License: Check for the 14-digit FSSAI license number and logo printed on the packaging.

3. Check Product Categories: Legitimate Indian dietary products will be explicitly classified under recognized categories such as “HEALTH SUPPLEMENT” or “NUTRACEUTICAL.”

4. Consult Healthcare Providers: Never substitute prescribed medical treatments with dietary supplements based on trade names or promotional illustrations.

What Happens Next?

With immediate prohibition orders active for FOLINEURO Syrup, any continued manufacture, storage, or distribution will trigger criminal penalties under the FSS Act. For Neuherbs TRUE VITAMIN, the 30-day window provides an opportunity for corrective labeling, though failure to comply will lead to complete license suspension.

FSSAI has signaled that inspection drives targeting non-compliant labeling, unapproved health claims, and hygiene lapses will continue across all major retail and e-commerce platforms throughout 2026.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

1. Economic Times Legal (July 30, 2026). “FSSAI bans sale of ‘FOLINEURO’ syrup, ‘Neuherbs TRUE VITAMIN’ over misleading claims.